Last update :
20/01/2021
Analgesic   Diamorphine hydrochloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Incompatibilities Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Diamorphine hydrochloride for injection Great Britain
Diaphin Switzerland
Stability of mixtures   Injection   Stability of mixtures : Diamorphine hydrochloride     
Container Solvent Concentration Compound Temperature Storage Length of time References
Polyvinyl chloride Sodium chloride 0,9% 0,02 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Bupivacaine hydrochloride 1,5 mg/ml
-18C
180 Day
Protect from light 512
Polyvinyl chloride Sodium chloride 0,9% 0,125 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Bupivacaine hydrochloride 1,25 mg/ml
25°C
28 Day
Light 1292
Polyvinyl chloride Sodium chloride 0,9% 0,02 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Bupivacaine hydrochloride 1,5 mg/ml
25°C
24 Hour
Light 512
Polyvinyl chloride Sodium chloride 0,9% 0,02 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Bupivacaine hydrochloride 1,5 mg/ml
7°C
14 Day
Protect from light 512
Polyvinyl chloride None 0,5 >> 10 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Bupivacaine hydrochloride 2,5 et 5 mg/ml
25°C
8 Day
Protect from light 2307
Polypropylene None 0,045 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Ropivacain hydrochloride 1 mg/ml
21°C
16 Day
Not specified 2051
Polypropylene None 0,045 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Ropivacain hydrochloride 1 mg/ml
40°C
6 Day
Not specified 2051
Polypropylene None 0,045 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Ropivacain hydrochloride 1 mg/ml
4°C
30 Day
Not specified 2051
Not specified None 0,025 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Ropivacain hydrochloride 2 mg/ml
21°C
28 Day
Not specified 2051
Not specified None 0,025 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Ropivacain hydrochloride 2 mg/ml
40°C
6 Day
Not specified 2051
Not specified None 0,025 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Ropivacain hydrochloride 2 mg/ml
4°C
70 Day
Not specified 2051
Polypropylen Syringe Water for Injection 20 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Cyclizine lactate 6,7 mg/ml
18-22°C
10 Day
Light 1886
Polypropylen Syringe Water for Injection 20 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Haloperidol lactate 0,75 mg/ml
18-22°C
20 Day
Light 1886
Polypropylen Syringe Water for Injection 0,66 & 33 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Midazolam hydrochloride 0,66 & 5 mg/ml
22°C
14 Day
Protect from light 1288
Polypropylen Syringe None 6,25 & 12,5 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Haloperidol lactate 0,31 mg/ml
22°C-24°C
24 Hour
With or without light 779
Polypropylen Syringe None 6,25 & 12,5 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Haloperidol lactate 0,31 mg/ml
4-8°C
7 Day
Protect from light 779
Polypropylen Syringe Glucose 8% 0,1 mg/ml
Injection   Diamorphine hydrochloride   
Injection   Bupivacaine hydrochloride 4 mg/ml
7°C
26 Day
Not specified 2308

  Mentions Légales